Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26
United States Fiscal year ends December CIK 0001640266
2.45
+3.38%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
2.45 on 9 Oct 2026
5 4 2 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $4.89 14 Oct 2025 $4.98 15 Oct 2025 $5.29 16 Oct 2025 $5.33 17 Oct 2025 $4.95 20 Oct 2025 $5.07 21 Oct 2025 $4.97 22 Oct 2025 $4.77 23 Oct 2025 $4.55 24 Oct 2025 $4.65 27 Oct 2025 $4.81 28 Oct 2025 $4.66 29 Oct 2025 $4.61 30 Oct 2025 $4.52 31 Oct 2025 $4.67 3 Nov 2025 $4.59 4 Nov 2025 $4.16 5 Nov 2025 $4.27 6 Nov 2025 $4.22 7 Nov 2025 $4.23 10 Nov 2025 $4.26 11 Nov 2025 $4.26 12 Nov 2025 $4.25 13 Nov 2025 $3.98 14 Nov 2025 $3.93 17 Nov 2025 $4.11 18 Nov 2025 $4.28 19 Nov 2025 $4.16 20 Nov 2025 $4.09 21 Nov 2025 $4.18 24 Nov 2025 $4.10 25 Nov 2025 $3.97 26 Nov 2025 $4.03 28 Nov 2025 $4.09 1 Dec 2025 $3.95 2 Dec 2025 $3.77 3 Dec 2025 $4.23 4 Dec 2025 $4.35 5 Dec 2025 $4.28 8 Dec 2025 $4.32 9 Dec 2025 $4.29 10 Dec 2025 $4.42 11 Dec 2025 $4.41 12 Dec 2025 $4.39 15 Dec 2025 $4.36 16 Dec 2025 $4.42 17 Dec 2025 $4.26 18 Dec 2025 $4.12 19 Dec 2025 $4.00 22 Dec 2025 $4.21 23 Dec 2025 $3.99 24 Dec 2025 $4.07 26 Dec 2025 $4.08 29 Dec 2025 $4.04 30 Dec 2025 $3.94 31 Dec 2025 $3.93 2 Jan 2026 $4.03 5 Jan 2026 $4.08 6 Jan 2026 $4.02 7 Jan 2026 $4.09 8 Jan 2026 $4.06 9 Jan 2026 $4.02 12 Jan 2026 $3.90 13 Jan 2026 $4.02 14 Jan 2026 $4.13 15 Jan 2026 $3.82 16 Jan 2026 $3.76 20 Jan 2026 $3.67 21 Jan 2026 $3.77 22 Jan 2026 $4.10 23 Jan 2026 $4.00 26 Jan 2026 $4.00 27 Jan 2026 $3.94 28 Jan 2026 $3.97 29 Jan 2026 $3.98 30 Jan 2026 $3.90 2 Feb 2026 $4.00 3 Feb 2026 $3.91 4 Feb 2026 $3.74 5 Feb 2026 $3.54 6 Feb 2026 $3.68 9 Feb 2026 $3.71 10 Feb 2026 $3.70 11 Feb 2026 $3.65 12 Feb 2026 $3.42 13 Feb 2026 $3.39 17 Feb 2026 $3.41 18 Feb 2026 $3.34 19 Feb 2026 $3.42 20 Feb 2026 $3.49 23 Feb 2026 $3.58 24 Feb 2026 $3.78 25 Feb 2026 $4.09 26 Feb 2026 $4.23 27 Feb 2026 $4.10 2 Mar 2026 $4.15 3 Mar 2026 $4.07 4 Mar 2026 $4.13 5 Mar 2026 $3.93 6 Mar 2026 $3.90 9 Mar 2026 $4.11 10 Mar 2026 $5.00 11 Mar 2026 $4.85 12 Mar 2026 $4.87 13 Mar 2026 $4.46 16 Mar 2026 $4.32 17 Mar 2026 $3.92 18 Mar 2026 $3.76 19 Mar 2026 $3.74 20 Mar 2026 $3.85 23 Mar 2026 $3.88 24 Mar 2026 $3.92 25 Mar 2026 $4.03 26 Mar 2026 $4.13 27 Mar 2026 $3.96 30 Mar 2026 $3.87 31 Mar 2026 $3.86 1 Apr 2026 $3.99 2 Apr 2026 $3.96 6 Apr 2026 $3.97 7 Apr 2026 $3.96 8 Apr 2026 $3.92 9 Apr 2026 $3.96 10 Apr 2026 $3.74 13 Apr 2026 $3.84 14 Apr 2026 $3.94 15 Apr 2026 $4.03 16 Apr 2026 $3.96 17 Apr 2026 $4.13 20 Apr 2026 $4.23 21 Apr 2026 $4.12 22 Apr 2026 $4.14 23 Apr 2026 $4.04 24 Apr 2026 $3.79 27 Apr 2026 $3.76 28 Apr 2026 $3.77 29 Apr 2026 $3.64 30 Apr 2026 $3.73 1 May 2026 $3.76 4 May 2026 $3.88 5 May 2026 $3.90 6 May 2026 $4.17 7 May 2026 $3.96 8 May 2026 $4.05 11 May 2026 $4.12 12 May 2026 $4.15 13 May 2026 $4.15 14 May 2026 $4.24 15 May 2026 $3.77 18 May 2026 $3.53 19 May 2026 $3.48 20 May 2026 $3.50 21 May 2026 $3.68 22 May 2026 $3.80 26 May 2026 $3.83 27 May 2026 $3.93 28 May 2026 $3.90 29 May 2026 $3.87 1 Jun 2026 $3.79 2 Jun 2026 $3.59 3 Jun 2026 $3.60 4 Jun 2026 $3.62 5 Jun 2026 $3.33 8 Jun 2026 $3.37 9 Jun 2026 $3.43 10 Jun 2026 $3.32 11 Jun 2026 $3.46 12 Jun 2026 $3.50 15 Jun 2026 $3.63 16 Jun 2026 $3.53 17 Jun 2026 $3.62 18 Jun 2026 $3.72 22 Jun 2026 $3.72 23 Jun 2026 $3.70 24 Jun 2026 $3.68 25 Jun 2026 $3.55 26 Jun 2026 $3.59 29 Jun 2026 $3.58 30 Jun 2026 $3.50 1 Jul 2026 $3.60 2 Jul 2026 $3.78 6 Jul 2026 $3.62 7 Jul 2026 $3.78 8 Jul 2026 $3.73 9 Jul 2026 $3.68 10 Jul 2026 $3.44 13 Jul 2026 $3.24 14 Jul 2026 $3.16 15 Jul 2026 $3.20 16 Jul 2026 $3.04 17 Jul 2026 $3.17 20 Jul 2026 $3.05 21 Jul 2026 $3.14 22 Jul 2026 $3.10 23 Jul 2026 $3.09 24 Jul 2026 $3.10 27 Jul 2026 $3.09 28 Jul 2026 $3.04 29 Jul 2026 $3.00 30 Jul 2026 $3.13 31 Jul 2026 $3.03 3 Aug 2026 $3.00 4 Aug 2026 $3.13 5 Aug 2026 $3.10 6 Aug 2026 $3.13 7 Aug 2026 $3.27 10 Aug 2026 $3.17 11 Aug 2026 $3.20 12 Aug 2026 $3.20 13 Aug 2026 $3.22 14 Aug 2026 $3.27 17 Aug 2026 $3.23 18 Aug 2026 $3.30 19 Aug 2026 $3.41 20 Aug 2026 $3.32 21 Aug 2026 $3.39 24 Aug 2026 $3.44 25 Aug 2026 $3.48 26 Aug 2026 $3.46 27 Aug 2026 $3.46 28 Aug 2026 $3.54 31 Aug 2026 $3.45 1 Sep 2026 $3.43 2 Sep 2026 $3.54 3 Sep 2026 $3.38 4 Sep 2026 $3.51 8 Sep 2026 $3.40 9 Sep 2026 $3.25 10 Sep 2026 $3.19 11 Sep 2026 $3.19 14 Sep 2026 $3.19 15 Sep 2026 $3.09 16 Sep 2026 $3.05 17 Sep 2026 $3.04 18 Sep 2026 $3.09 21 Sep 2026 $3.08 22 Sep 2026 $3.14 23 Sep 2026 $2.87 24 Sep 2026 $2.80 25 Sep 2026 $2.68 28 Sep 2026 $2.70 29 Sep 2026 $2.64 30 Sep 2026 $2.68 1 Oct 2026 $2.68 2 Oct 2026 $2.45 5 Oct 2026 $2.46 6 Oct 2026 $2.46 7 Oct 2026 $2.47 8 Oct 2026 $2.37 9 Oct 2026 $2.45 Carter Todd Alfred Chief Scientific Officer Sold at will $13.57K 10 Feb 2026 · at $3.85 · 2.2% of stake Swartz Robin COO & CBO Sold at will $17.59K 10 Feb 2026 · at $3.85 · 2.1% of stake Sandrock Alfred President and CEO Sold at will $46.09K 10 Feb 2026 · at $3.78 · 2.3% of stake Carter Todd Alfred Chief Scientific Officer Sold on a plan $11.36K 18 Feb 2026 · at $3.44 · 2.2% of stake Swartz Robin COO & CBO Sold on a plan $13.35K 18 Feb 2026 · at $3.44 · 1.8% of stake Sandrock Alfred President and CEO Sold on a plan $40.01K 18 Feb 2026 · at $3.41 · 2.3% of stake Carter Todd Alfred Chief Scientific Officer Sold on a plan $15.69K 24 Feb 2026 · at $3.76 · 2.8% of stake Jorgensen Nathan D. Chief Financial Officer Sold on a plan $17.60K 24 Feb 2026 · at $3.77 · 3.0% of stake Swartz Robin COO & CBO Sold on a plan $24.35K 24 Feb 2026 · at $3.77 · 3.1% of stake Sandrock Alfred President and CEO Sold on a plan $53.81K 24 Feb 2026 · at $3.79 · 2.8% of stake Sandrock Alfred President and CEO Sold on a plan $44.55K 2 Apr 2026 · at $3.87 · 2.4% of stake
0 buys3 sales at will8 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$40.37M
Net income
$119.72M
Free cash flow
$135.06M
Operating margin
-326.6%
Net margin
-296.5%
Return on equity
-61.1%
Return on capital
-53.1%
Revenue growth, 1 yr
-49.5%
Revenue growth, 5 yr
-25.1% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
171M 37M FY20 Fiscal year 2020 Revenue $171.13M Net income $36.74M Margin 21.5% 37M -71M FY21 Fiscal year 2021 Revenue $37.42M Net income $71.20M Margin -190.3% · growth -78.1% 41M -46M FY22 Fiscal year 2022 Revenue $40.91M Net income $46.41M Margin -113.4% · growth +9.3% 250M 132M FY23 Fiscal year 2023 Revenue $250.01M Net income $132.33M Margin 52.9% · growth +511.2% 80M -65M FY24 Fiscal year 2024 Revenue $80.00M Net income $65.00M Margin -81.3% · growth -68.0% 40M -120M FY25 Fiscal year 2025 Revenue $40.37M Net income $119.72M Margin -296.5% · growth -49.5%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
2 Apr 2026 Sandrock Alfred
President and CEO
Sold on a plan $44.55K 2.4%
24 Feb 2026 Sandrock Alfred
President and CEO
Sold on a plan $53.81K 2.8%
24 Feb 2026 Swartz Robin
COO & CBO
Sold on a plan $24.35K 3.1%
24 Feb 2026 Jorgensen Nathan D.
Chief Financial Officer
Sold on a plan $17.60K 3.0%
24 Feb 2026 Carter Todd Alfred
Chief Scientific Officer
Sold on a plan $15.69K 2.8%
18 Feb 2026 Sandrock Alfred
President and CEO
Sold on a plan $40.01K 2.3%